what type of drug is tirzepatide FDA approves tirzepatide, Eli Lilly's new 2 diabetes drug, and the company shares an estimated price How the weight loss drug

Secondary outcomes encompass MACEs, including stroke (either ischemic or hemorrhagic), acute myocardial infarction (AMI), cardiac arrest, cardiogenic shock or death, as well as major adverse kidney events (MAKEs), which is defined as a composite of dialysis dependence, an eGFR less than 15 mL/min/1.73 m, or death

Tirzepatide takes it a step further by combining the actions of two hormones, enhancing not just satiety but also improving the way your body handles sugar

The SURMOUNT-1 Phase 3 trial demonstrated that tirzepatide 15mg weekly produced 20.9% mean body weight reduction versus 3.1% placebo

While it is mainly used for treating type 2 diabetes and obesity, questions have been raised about its possible connection to pancreas problems